Smoking Cessation For Youth Project Booster And Cohort Tracking Study
Funder
National Health and Medical Research Council
Funding Amount
$135,550.00
Summary
Adolescence is a critical period for the establishment of adult drug use behaviours. If smoking does not commence in teenage years it is unlikely to occur. This innovative project not only continues to address tobacco control with this important age group but also builds on evidence from a randomised intervention trial involving over 4,000 Year 9 students tracked over two years. This project was called the Smoking Cessation for Youth Project (SCYP). Preliminary longitudinal analyses of the SCYP ....Adolescence is a critical period for the establishment of adult drug use behaviours. If smoking does not commence in teenage years it is unlikely to occur. This innovative project not only continues to address tobacco control with this important age group but also builds on evidence from a randomised intervention trial involving over 4,000 Year 9 students tracked over two years. This project was called the Smoking Cessation for Youth Project (SCYP). Preliminary longitudinal analyses of the SCYP data indicate that the intervention students were significantly less likely to smoke heavily (smoking five or more days per week) than the control group and that intervention students were also significantly less likely to have tried smoking than the control group. These results represent a world first in evidence that population-based smoking cessation interventions among teenagers can be successful. The proposed project will determine the extent to which these positive intervention effects are sustainable, two years post intervention, as our cohort moves into Year 12. In addition to tracking the possible decay of SCYP intervention effects, the proposed project will also measure the effects of a booster intervention delivered students when they are in Year 12 (2002). The Year 12 intervention will comprise an innovative self-help 'magazine style' booster and a supportive environmental intervention involving school nurses and local GPs. This proposal represents a cost-effective opportunity to measure the effectiveness of a Year 12 tobacco cessation booster intervention. Further data on tobacco smoking behaviour in 2002 will also enable us to determine how long the SCYP intervention appears to affect behaviour and whether 'boosters' are needed in later secondary school years to maintain the benefits.Read moreRead less
Mass Disseminable Approaches To Smoking Cessation In General Practice
Funder
National Health and Medical Research Council
Funding Amount
$412,100.00
Summary
Tobacco smoking is the most significant preventable cause of mortality in Australia. At any one time, many smokers want to quit. There are several interventions that are known to work in research settings, such as advice from care providers, self-help materials, drug therapies and telephone counselling. This study wants to find out if these strategies work in ordinary general practice. Over 50% of Australian have access to the Internet and research suggests that seeking health information is one ....Tobacco smoking is the most significant preventable cause of mortality in Australia. At any one time, many smokers want to quit. There are several interventions that are known to work in research settings, such as advice from care providers, self-help materials, drug therapies and telephone counselling. This study wants to find out if these strategies work in ordinary general practice. Over 50% of Australian have access to the Internet and research suggests that seeking health information is one of the most common uses of this technology. The rapid growth of Internet use potentially provides access to a number of cessation aids for tobacco smokers, including online support through 'chat rooms'. It is also possible to tailor interventions to individuals according to their stated interests and readiness to quit. General practitioners, in addition to providing support and care to smokers attemtping to quit, can direct them to community services such as Quit Victoria, which now offers smoking cessation programs tailored to individuals' needs delivered either through telephone counselling or by the Internet. We want to know whether more smokers quit successfully if their GP refers them to Quit services in addition to their usual care. As well as assessing the effectiveness of broadly distributable interventions in smoking cessation, this project will also collect data about the use of the Internet for health research. Little is known about how to perform research on the Web. This project will allow automatic monitoring of how people respond to research endeavours in this environment.Read moreRead less
Unintended Adverse Effects Of Advertising For Nicotine Replacement Therapies
Funder
National Health and Medical Research Council
Funding Amount
$133,250.00
Summary
Advertising for certain pharmaceutical products (nicotine replacement therapy( NRT)) to help people quit smoking has been permitted in Australia since 1997. Zyban, an antidepressant drug, has been found to be helpful in quitting smoking, but advertising has not yet been permitted in Australia although it is allowed overseas. Because such advertising will reach more than the primary target group of heavy smokers ready to quit, it is important to consider the responses of other smokers who are not ....Advertising for certain pharmaceutical products (nicotine replacement therapy( NRT)) to help people quit smoking has been permitted in Australia since 1997. Zyban, an antidepressant drug, has been found to be helpful in quitting smoking, but advertising has not yet been permitted in Australia although it is allowed overseas. Because such advertising will reach more than the primary target group of heavy smokers ready to quit, it is important to consider the responses of other smokers who are not ready to quit and those at risk of taking up smoking. There is concern that there may be 'boomerang' effects, albeit unintended, on these population groups, because they may feel reassured that there is an effective method to quit and so be in no rush to quit soon, they may try to quit using these products before they are really ready, and in the case of teenagers, they may think that these products make it easy to quit, so there is less problem with starting to smoke. In order to assess if this is so, we will randomly allocate smokers not yet ready to quit and teenagers to either (a) a group where they view 3 ads promoting non-drug methods of quitting, such as the Quitline, (b) a group where they view 3 ads promoting the NRT gum or patch, or (c) a group where they view 3 ads promoting Zyban as a method for quitting. The study will use questionnaires to assess whether, compared with those viewing the non-drug anti-smoking ads, those viewing the NRT or Zyban ads think smoking is less addictive and have less intention to quit, or in the case of teenagers, have more intention to take up smoking. This project will be the first formal study to assess whether there may be adverse effects of NRT and Zyban advertising on smokers not yet ready to quit and teenagers who are not already regular smokers. For this reason, the study will help an assessment of the risks of such advertising compared with the established benefits for smokers who are ready to quit.Read moreRead less
Smoking Cessation And Bone Health: Observational And Intervention Studies In Twins And A Quitline Population
Funder
National Health and Medical Research Council
Funding Amount
$639,050.00
Summary
Osteoporosis is a major health problem that causes bones to break (fracture) easily. Many bones are susceptible, with hip fractures being the worst outcome of osteoporosis. They cause pain, disability, require major health interventions (surgery and rehabilitation), lead to death in about 20% of cases, and the overall care of hip fracture patients is very expensive. Osteoporosis is treated to reduce the risk of fractures. The prevention and treatment of osteoporosis should include avoidance of f ....Osteoporosis is a major health problem that causes bones to break (fracture) easily. Many bones are susceptible, with hip fractures being the worst outcome of osteoporosis. They cause pain, disability, require major health interventions (surgery and rehabilitation), lead to death in about 20% of cases, and the overall care of hip fracture patients is very expensive. Osteoporosis is treated to reduce the risk of fractures. The prevention and treatment of osteoporosis should include avoidance of factors known to bring on or worsen the condition. Smokers are known to have an increased risk of osteoporosis and fractures. However, it is not known how smoking brings on osteoporosis. Importantly, neither is it clear whether quitting smoking leads to improved bone health (and a reduced risk of fractures). These are important questions for the community in general and for smokers with osteoporosis in particular. We will endeavour to answer these questions by studying twins who do and do not smoke and by observing what happens to measures of bone health (bone mineral density and other factors) in people attempting to quit smoking. New information gained from these studies may lead to better ways of avoiding or treating the damage that smoking does to bone. We may also become able to predict the benefit to bone when people quit smoking.Read moreRead less
A Multi-component Intervention For Smoking Cessation Among Australian Male Prison Inmates
Funder
National Health and Medical Research Council
Funding Amount
$551,500.00
Summary
The prevalence of smoking amongst the Australian prison population is much higher than that in the general community. Despite a perception that prison inmates are unlikely to give up smoking while in prison, a recent survey has found that many inmates have attempted to quit or have reduced the amount they smoke. The same survey reported that almost a quarter of male inmates were planning to give up smoking within the next three months. Depression and anxiety are common among prison inmates. Rese ....The prevalence of smoking amongst the Australian prison population is much higher than that in the general community. Despite a perception that prison inmates are unlikely to give up smoking while in prison, a recent survey has found that many inmates have attempted to quit or have reduced the amount they smoke. The same survey reported that almost a quarter of male inmates were planning to give up smoking within the next three months. Depression and anxiety are common among prison inmates. Research has shown that people with depression or anxiety problems are less likely to quit, and more likely to relapse, than smokers without these symptoms. For this reason there has been interest in incorporating antidepressant medications into quit strategies. As a group with a high prevalence of depression and anxiety, prisoners may benefit from an intervention strategy that includes an antidepressant medication. Prisoners are often poorly educated, on a low income or benefits, or from a lower socioeconomic or an indigenous background. Members of this disadvantaged group have been shown to be less likely to use preventive health services, such as smoking cessation programs. This research proposal represents the first large scale randomised controlled trial of a multi-component intervention for tobacco dependence amongst a prisoner population in the world. This project will compare the effectiveness of adding an antidepressant medication to counselling, nicotine replacement therapy, a coping with change package and referral to a Quitline. The proposed research follows a small pilot study of the feasibility of a similar intervention. It brings together the expertise of several people across Australia with experience in tobacco dependence and prison research. The results will inform future smoking interventions for prison inmates and offers a real opportunity to impact upon the health and well-being of some of the most marginalised groups in Australian society.Read moreRead less